GAMMA Investing LLC Purchases 173,836 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

GAMMA Investing LLC increased its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 7,291.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 176,220 shares of the company's stock after buying an additional 173,836 shares during the quarter. GAMMA Investing LLC owned about 0.19% of Acadia Healthcare worth $5,812,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of ACHC. Treasurer of the State of North Carolina grew its position in shares of Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock worth $1,586,000 after acquiring an additional 250 shares in the last quarter. Coldstream Capital Management Inc. grew its position in shares of Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock worth $257,000 after acquiring an additional 303 shares in the last quarter. Covestor Ltd grew its position in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock worth $58,000 after acquiring an additional 310 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after purchasing an additional 345 shares during the last quarter. Finally, Xponance Inc. lifted its holdings in shares of Acadia Healthcare by 5.9% in the 4th quarter. Xponance Inc. now owns 10,530 shares of the company's stock worth $418,000 after purchasing an additional 590 shares during the last quarter.

Analysts Set New Price Targets

ACHC has been the topic of several recent research reports. Barclays cut their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a report on Wednesday, May 14th. Bank of America lowered their price target on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. KeyCorp lowered their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Guggenheim began coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price target on the stock. Finally, Royal Bank of Canada lowered their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Trading Down 4.1%

Shares of ACHC stock traded down $0.90 during trading hours on Friday, reaching $21.23. The company had a trading volume of 1,739,832 shares, compared to its average volume of 1,767,076. The company has a 50 day moving average of $23.89 and a 200 day moving average of $33.31. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The firm has a market cap of $1.96 billion, a price-to-earnings ratio of 6.96, a P/E/G ratio of 1.46 and a beta of 0.94. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm's quarterly revenue was up .3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.84 EPS. On average, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.